| Home |
About |
Network |
Latest News
March 2013
Joint J Med Chem publication with Cyclofluidic
on design of novel Abl kinase inhibitors
February 2013
Sandexis move to new premises in Innovation
House, Discovery Park in Sandwich, Kent
November 2012
Sandexis and Mission Therapeutics announce
multi-project medicinal chemistry support agreement
(press release)
March 2012
Sandexis and Cyclofluidic announce
medicinal chemistry strategic agreement
(press release)
.
March 2012
Karl visiting lecturer at Greenwich University.
February 2012
James running workshop at SMI's
Advances and Progress in Drug Design:
Virtual Screening Strategies in London.
December 2011
Karl tutoring at 4th EFMC Short Course in
Medicinal Chemistry: Safety and Attrition
Workshop in Oegstgeest, Netherlands
October 2011
Sandexis LLP formed
Sandexis LLP is a partnership of highly experienced PhD medicinal and computational chemists working at the cutting edge of modern medicinal chemistry. The partners have more than 45 years of collective experience at Pfizer and Merck, encompassing 10 clinical candidates across multiple disease areas.
We provide the following medicinal and computational chemistry design services (click
for further details):
Expert design support
for all stages of drug discovery from hit generation
through to candidate identification Management of
integrated drug discovery projects and outsourced
synthetic chemistry Generation and
optimisation of intellectual property Consultancy for due
diligence, project reviews, proposal advice, problem
solving, expert witness and literature searches Design and delivery of medicinal
and computational chemistry training solutions